SCM Lifescience listed on Kosdaq

On Oct 25,2018, Duopharma Biotech had acquired a 5.8% stake in SCM Lifescience for 5.5 billion won or RM20.24mil.

KUALA LUMPUR: Duopharma Biotech Bhd’s investee company, SCM Lifescience Co Ltd has been listed on Kosdaq, which is a trading board of Korea Exchange in South Korea.

SCM Lifescience specialises in stem cell therapeutics with proprietary platform technology in the field of high-purity isolation and cultivation of mesenchymal stem cells and is currently focusing on autoimmune diseases.